Gracell Biotechnologies
A Member of the AstraZeneca Group
33 employees · est. 2017 · Shanghai, China
Vor Bio
Vor Bio's vision is to cure blood cancers through cell and genome engineering.
110 employees · est. 2016 · Cambridge, United States
Vor Bio is the older company (2017 vs 2016); Vor Bio is the larger of the two.
Side-by-Side Comparison
| Metric | Gracell Biotechnologies | Vor Bio |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2016 older |
| Headquarters | ||
| Headquarters | Shanghai, China | Cambridge, United States |
| Employees | ||
| Employees | 33 | 110 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Acquired | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $1.29B | $267.80M |
| Funding Rounds | ||
| Funding Rounds | 6 | 3 |
| Services | ||
| Services | Cell Therapy Development, Innovative CAR-T Technologies, Next-Generation Therapeutic Solutions | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer Patients, Patients with Autoimmune Diseases, Medical Institutions Seeking Advanced Therapies, Healthcare Providers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceuticals, Clinical-stage, Cell Therapy, Autologous Therapy, Allogeneic Therapy, Cancer Treatment, Autoimmune Diseases, Hematological Malignancies, Solid Tumors, FasTCAR Technology, TruUCAR Technology, SMART CART Technology, R&D, Cellular Therapeutics, Immunotherapy | Biopharma, Genome Engineering, Cell Therapy, Cancer Treatment, Immuno-oncology, Clinical-stage Company, Hematopoietic Stem Cells, Targeted Therapies, Selective Targeting, Therapy Development, Immunotherapies, Bi-specific Antibodies, CAR-T Therapy, Toxicity Management, Cancer Research |
| Website | ||
| Website | gracellbio.com | vorbio.com |
About Gracell Biotechnologies
Gracell Biotechnologies, a prominent player within the biopharmaceutical sector, stands as a global clinical-stage company under the esteemed umbrella of the AstraZeneca Group. Founded in 2017 and headquartered in China, Gracell is at the forefront of pioneering cutting-edge solutions for cancer and...
About Vor Bio
Vor Bio is a biotechnology startup founded in 2016 with a vision to cure blood cancers through cell and genome engineering. The company's slogan, "Vor Bio's vision is to cure blood cancers through cell and genome engineering," encapsulates its ambitious goal. Vor Bio is a clinical-stage company base...
We will tell you when either one moves
BounceWatch watches Gracell Biotechnologies and Vor Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Gracell Biotechnologie... and Vor Bio — by email.
Frequently Asked Questions
Compare Gracell Biotechnologies with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Gracell Biotechnologies on 23 Jun 2026, and Vor Bio on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.